China Regenerative Medicine International

China Regenerative Medicine International manufacturing company for gene and stem cell products.

Business Model:

Revenue: $0

Employees: 201-500

Rankings

Detailed China Regenerative Medicine International Information

Geographic Data

China Regenerative Medicine International headquarters map

Address:

City: Wan Chai

State: Hong Kong Island

Zip:

Country: Hong Kong

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

China Regenerative Medicine International manufacturing company for gene and stem cell products. China Regenerative Medicine International Limited (“CRMI”), listed on The Stock Exchange of Hong Kong Limited on 18 July 2001 (Stock Code: 8158.HK), is China’s first high-end new-technology enterprise principally engaged in research and development, production and sales of tissue engineering and regenerative medicine products. After unremitting efforts over the past decades, CRMI has evolved into a tissue engineering pioneer and has successfully industrialized regenerative medicine in the People’s Republic of China (P.R.C.), as well as accomplished the research and development and commercialization platform of tissue engineering. Headquartered in Hong Kong, CRMI has six modernized manufacturing facilities in Xi’an, Shenzhen, Suzhou, Tianjin and Hong Kong. Currently, CRMI has applied for more than 140 domestic and overseas patents and over 170 trademarks, and has undertaken various national pivotal projects. CRMI has presided over the development of the industry standard on two occasions, and has also received many significant scientific awards including the First Class Award of the National Science and Significant Scientific Technology Award. In 2014, CRMI collaborated with the University of Oxford in the UK to establish the‘CRMI Technology Centre at the University of Oxford’ where CRMI has designated it as its core R&a;D institution. Following the Rolls-Royce Group and Invensys Group, CRMI is the third enterprise to set up a technology and R &a; D centre with the University of Oxford. On 21st October 2015, CRMI has jointly entered into the memorandum of understanding with the University of Oxford and CCB International (Holdings) Ltd, during the State Visit to the United Kingdom by President Xi Jinping of the PRC. The memorandum depicts the establishment of a strategic platform for industrialization of biomedical research which is one of the 28 projects being selected during President Xi’s visit

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
Announced Date Name Price
7/2017 Obagi Medical Products

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research